NO844376L - Fremgangsmaate for fremstilling av terapeutisk aktive pyrazolopyridin-cykloalkanon-derivater - Google Patents
Fremgangsmaate for fremstilling av terapeutisk aktive pyrazolopyridin-cykloalkanon-derivaterInfo
- Publication number
- NO844376L NO844376L NO844376A NO844376A NO844376L NO 844376 L NO844376 L NO 844376L NO 844376 A NO844376 A NO 844376A NO 844376 A NO844376 A NO 844376A NO 844376 L NO844376 L NO 844376L
- Authority
- NO
- Norway
- Prior art keywords
- carbon atoms
- alkyl
- formula
- hexane
- halogen
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims description 78
- 238000002360 preparation method Methods 0.000 title description 4
- 230000001225 therapeutic effect Effects 0.000 title 1
- 125000004432 carbon atom Chemical group C* 0.000 claims description 245
- 150000001875 compounds Chemical class 0.000 claims description 144
- 125000000217 alkyl group Chemical group 0.000 claims description 109
- 229910052739 hydrogen Inorganic materials 0.000 claims description 79
- 239000001257 hydrogen Substances 0.000 claims description 50
- 125000001424 substituent group Chemical group 0.000 claims description 47
- 229910052736 halogen Inorganic materials 0.000 claims description 37
- 150000002367 halogens Chemical class 0.000 claims description 36
- 238000006243 chemical reaction Methods 0.000 claims description 32
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 29
- 125000003118 aryl group Chemical group 0.000 claims description 24
- 125000003545 alkoxy group Chemical group 0.000 claims description 22
- 125000003342 alkenyl group Chemical group 0.000 claims description 20
- 150000002431 hydrogen Chemical class 0.000 claims description 19
- 125000005843 halogen group Chemical group 0.000 claims description 17
- 150000003839 salts Chemical class 0.000 claims description 14
- 125000001188 haloalkyl group Chemical group 0.000 claims description 13
- 125000000392 cycloalkenyl group Chemical group 0.000 claims description 12
- 125000001153 fluoro group Chemical group F* 0.000 claims description 12
- 125000000304 alkynyl group Chemical group 0.000 claims description 11
- 229910052799 carbon Inorganic materials 0.000 claims description 11
- 125000004093 cyano group Chemical group *C#N 0.000 claims description 11
- 125000004043 oxo group Chemical group O=* 0.000 claims description 11
- 238000007363 ring formation reaction Methods 0.000 claims description 11
- 125000003003 spiro group Chemical group 0.000 claims description 9
- 125000004453 alkoxycarbonyl group Chemical group 0.000 claims description 8
- 125000003277 amino group Chemical class 0.000 claims description 8
- 125000003710 aryl alkyl group Chemical group 0.000 claims description 8
- 125000001316 cycloalkyl alkyl group Chemical group 0.000 claims description 8
- 125000000753 cycloalkyl group Chemical group 0.000 claims description 8
- 239000002253 acid Substances 0.000 claims description 7
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims description 7
- 125000004103 aminoalkyl group Chemical group 0.000 claims description 6
- 238000004519 manufacturing process Methods 0.000 claims description 4
- GYESAYHWISMZOK-UHFFFAOYSA-N quinolin-5-ol Chemical compound C1=CC=C2C(O)=CC=CC2=N1 GYESAYHWISMZOK-UHFFFAOYSA-N 0.000 claims description 4
- RTUREOKDTCTFBC-UHFFFAOYSA-N 8-amino-4-pentyl-11-propyl-2,4,5-triazatricyclo[7.3.0.03,7]dodeca-1(9),2,5,7-tetraen-10-one Chemical compound N1=C2N(CCCCC)N=CC2=C(N)C2=C1CC(CCC)C2=O RTUREOKDTCTFBC-UHFFFAOYSA-N 0.000 claims description 2
- 125000003435 aroyl group Chemical group 0.000 claims description 2
- 239000012458 free base Substances 0.000 claims description 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims 13
- 125000001589 carboacyl group Chemical group 0.000 claims 7
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 630
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 549
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 200
- 239000000741 silica gel Substances 0.000 description 200
- 229910002027 silica gel Inorganic materials 0.000 description 200
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 142
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 129
- 239000000203 mixture Substances 0.000 description 98
- 239000000243 solution Substances 0.000 description 98
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 90
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 78
- ZCSHNCUQKCANBX-UHFFFAOYSA-N lithium diisopropylamide Chemical compound [Li+].CC(C)[N-]C(C)C ZCSHNCUQKCANBX-UHFFFAOYSA-N 0.000 description 70
- 239000012043 crude product Substances 0.000 description 69
- 239000000047 product Substances 0.000 description 68
- 239000003480 eluent Substances 0.000 description 67
- 239000007787 solid Substances 0.000 description 66
- UAOMVDZJSHZZME-UHFFFAOYSA-N diisopropylamine Chemical compound CC(C)NC(C)C UAOMVDZJSHZZME-UHFFFAOYSA-N 0.000 description 64
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 64
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 61
- -1 derivatives of 10 Chemical class 0.000 description 61
- 125000001147 pentyl group Chemical group C(CCCC)* 0.000 description 56
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 55
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 48
- 239000003921 oil Substances 0.000 description 46
- 235000019198 oils Nutrition 0.000 description 46
- 125000005594 diketone group Chemical group 0.000 description 45
- 150000002576 ketones Chemical class 0.000 description 45
- MZRVEZGGRBJDDB-UHFFFAOYSA-N N-Butyllithium Chemical compound [Li]CCCC MZRVEZGGRBJDDB-UHFFFAOYSA-N 0.000 description 44
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 41
- 150000002081 enamines Chemical class 0.000 description 41
- 238000004440 column chromatography Methods 0.000 description 40
- 238000001819 mass spectrum Methods 0.000 description 40
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 39
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 38
- 238000000921 elemental analysis Methods 0.000 description 38
- BZLVMXJERCGZMT-UHFFFAOYSA-N Methyl tert-butyl ether Chemical compound COC(C)(C)C BZLVMXJERCGZMT-UHFFFAOYSA-N 0.000 description 36
- WTKZEGDFNFYCGP-UHFFFAOYSA-N Pyrazole Chemical compound C=1C=NNC=1 WTKZEGDFNFYCGP-UHFFFAOYSA-N 0.000 description 35
- 239000010410 layer Substances 0.000 description 32
- 238000010626 work up procedure Methods 0.000 description 32
- 238000001953 recrystallisation Methods 0.000 description 29
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 description 26
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 26
- 239000012074 organic phase Substances 0.000 description 26
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 24
- 239000012267 brine Substances 0.000 description 24
- 238000001816 cooling Methods 0.000 description 24
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 24
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 24
- 238000003756 stirring Methods 0.000 description 23
- 239000008346 aqueous phase Substances 0.000 description 21
- 229940043279 diisopropylamine Drugs 0.000 description 21
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 21
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 20
- DKPFZGUDAPQIHT-UHFFFAOYSA-N butyl acetate Chemical compound CCCCOC(C)=O DKPFZGUDAPQIHT-UHFFFAOYSA-N 0.000 description 19
- GNOIPBMMFNIUFM-UHFFFAOYSA-N hexamethylphosphoric triamide Chemical compound CN(C)P(=O)(N(C)C)N(C)C GNOIPBMMFNIUFM-UHFFFAOYSA-N 0.000 description 19
- 125000004356 hydroxy functional group Chemical group O* 0.000 description 17
- 238000012360 testing method Methods 0.000 description 16
- JWCFJPLIRVYENQ-UHFFFAOYSA-N 3-ethoxycyclohex-2-en-1-one Chemical compound CCOC1=CC(=O)CCC1 JWCFJPLIRVYENQ-UHFFFAOYSA-N 0.000 description 15
- OAYLNYINCPYISS-UHFFFAOYSA-N ethyl acetate;hexane Chemical compound CCCCCC.CCOC(C)=O OAYLNYINCPYISS-UHFFFAOYSA-N 0.000 description 15
- 229920006395 saturated elastomer Polymers 0.000 description 15
- RFKZUAOAYVHBOY-UHFFFAOYSA-M copper(1+);acetate Chemical compound [Cu+].CC([O-])=O RFKZUAOAYVHBOY-UHFFFAOYSA-M 0.000 description 14
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 14
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 14
- 241001465754 Metazoa Species 0.000 description 13
- GQHTUMJGOHRCHB-UHFFFAOYSA-N 2,3,4,6,7,8,9,10-octahydropyrimido[1,2-a]azepine Chemical compound C1CCCCN2CCCN=C21 GQHTUMJGOHRCHB-UHFFFAOYSA-N 0.000 description 12
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 12
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 12
- 238000010438 heat treatment Methods 0.000 description 12
- 239000011780 sodium chloride Substances 0.000 description 12
- 150000001450 anions Chemical class 0.000 description 11
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 11
- 239000000460 chlorine Substances 0.000 description 11
- 238000004587 chromatography analysis Methods 0.000 description 11
- 239000000543 intermediate Substances 0.000 description 11
- 239000000725 suspension Substances 0.000 description 11
- IMNFDUFMRHMDMM-UHFFFAOYSA-N N-Heptane Chemical compound CCCCCCC IMNFDUFMRHMDMM-UHFFFAOYSA-N 0.000 description 10
- 241000700159 Rattus Species 0.000 description 10
- 230000003197 catalytic effect Effects 0.000 description 10
- ZXEKIIBDNHEJCQ-UHFFFAOYSA-N isobutanol Chemical compound CC(C)CO ZXEKIIBDNHEJCQ-UHFFFAOYSA-N 0.000 description 10
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 10
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 10
- 238000010992 reflux Methods 0.000 description 10
- 239000002904 solvent Substances 0.000 description 10
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 9
- PPTYJKAXVCCBDU-UHFFFAOYSA-N Rohypnol Chemical compound N=1CC(=O)N(C)C2=CC=C([N+]([O-])=O)C=C2C=1C1=CC=CC=C1F PPTYJKAXVCCBDU-UHFFFAOYSA-N 0.000 description 9
- 239000002168 alkylating agent Substances 0.000 description 9
- 229940100198 alkylating agent Drugs 0.000 description 9
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 9
- 239000013078 crystal Substances 0.000 description 9
- 230000000694 effects Effects 0.000 description 9
- 239000007788 liquid Substances 0.000 description 9
- 239000000463 material Substances 0.000 description 9
- 239000011541 reaction mixture Substances 0.000 description 9
- 239000011734 sodium Substances 0.000 description 9
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 8
- 238000005481 NMR spectroscopy Methods 0.000 description 8
- 125000002252 acyl group Chemical group 0.000 description 8
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 8
- HJSLFCCWAKVHIW-UHFFFAOYSA-N cyclohexane-1,3-dione Chemical compound O=C1CCCC(=O)C1 HJSLFCCWAKVHIW-UHFFFAOYSA-N 0.000 description 8
- 239000003814 drug Substances 0.000 description 8
- 230000035939 shock Effects 0.000 description 8
- 229910000104 sodium hydride Inorganic materials 0.000 description 8
- UTJFUDRUZRBQJZ-UHFFFAOYSA-N 3-(2-methylpropoxy)cyclopent-2-en-1-one Chemical compound CC(C)COC1=CC(=O)CC1 UTJFUDRUZRBQJZ-UHFFFAOYSA-N 0.000 description 7
- HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 7
- OKJPEAGHQZHRQV-UHFFFAOYSA-N Triiodomethane Natural products IC(I)I OKJPEAGHQZHRQV-UHFFFAOYSA-N 0.000 description 7
- 230000027455 binding Effects 0.000 description 7
- 229910052801 chlorine Inorganic materials 0.000 description 7
- 229940079593 drug Drugs 0.000 description 7
- INQOMBQAUSQDDS-UHFFFAOYSA-N iodomethane Chemical compound IC INQOMBQAUSQDDS-UHFFFAOYSA-N 0.000 description 7
- 238000000746 purification Methods 0.000 description 7
- 125000001340 2-chloroethyl group Chemical group [H]C([H])(Cl)C([H])([H])* 0.000 description 6
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 6
- 238000009835 boiling Methods 0.000 description 6
- 238000001914 filtration Methods 0.000 description 6
- 229960002200 flunitrazepam Drugs 0.000 description 6
- 238000011835 investigation Methods 0.000 description 6
- HVTICUPFWKNHNG-UHFFFAOYSA-N iodoethane Chemical compound CCI HVTICUPFWKNHNG-UHFFFAOYSA-N 0.000 description 6
- 229910052757 nitrogen Inorganic materials 0.000 description 6
- FVAUCKIRQBBSSJ-UHFFFAOYSA-M sodium iodide Chemical compound [Na+].[I-] FVAUCKIRQBBSSJ-UHFFFAOYSA-M 0.000 description 6
- JLTRXTDYQLMHGR-UHFFFAOYSA-N trimethylaluminium Chemical compound C[Al](C)C JLTRXTDYQLMHGR-UHFFFAOYSA-N 0.000 description 6
- XXTLMXOGRBXMQF-UHFFFAOYSA-N 5-bromopent-2-yne Chemical compound CC#CCCBr XXTLMXOGRBXMQF-UHFFFAOYSA-N 0.000 description 5
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 5
- 239000006184 cosolvent Substances 0.000 description 5
- 238000001035 drying Methods 0.000 description 5
- 229910052731 fluorine Inorganic materials 0.000 description 5
- FUZZWVXGSFPDMH-UHFFFAOYSA-M hexanoate Chemical compound CCCCCC([O-])=O FUZZWVXGSFPDMH-UHFFFAOYSA-M 0.000 description 5
- 229910000027 potassium carbonate Inorganic materials 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- 238000006467 substitution reaction Methods 0.000 description 5
- NUGZBVBZIDWZAD-UHFFFAOYSA-N 1h-pyrazole-4-carbonitrile Chemical class N#CC=1C=NNC=1 NUGZBVBZIDWZAD-UHFFFAOYSA-N 0.000 description 4
- YMJLEPMVGQBLHL-UHFFFAOYSA-N 1h-pyrazole-5-carbonitrile Chemical compound N#CC1=CC=NN1 YMJLEPMVGQBLHL-UHFFFAOYSA-N 0.000 description 4
- KGIWPGKKIFFMKP-UHFFFAOYSA-N 2-(ethoxymethylidene)-3-hydroxybutanedinitrile Chemical compound CCOC=C(C#N)C(O)C#N KGIWPGKKIFFMKP-UHFFFAOYSA-N 0.000 description 4
- 125000000069 2-butynyl group Chemical group [H]C([H])([H])C#CC([H])([H])* 0.000 description 4
- 125000004975 3-butenyl group Chemical group C(CC=C)* 0.000 description 4
- 208000019901 Anxiety disease Diseases 0.000 description 4
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 4
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 4
- 230000000949 anxiolytic effect Effects 0.000 description 4
- 230000015572 biosynthetic process Effects 0.000 description 4
- YKYOUMDCQGMQQO-UHFFFAOYSA-L cadmium dichloride Chemical compound Cl[Cd]Cl YKYOUMDCQGMQQO-UHFFFAOYSA-L 0.000 description 4
- 239000012230 colorless oil Substances 0.000 description 4
- LOGSONSNCYTHPS-UHFFFAOYSA-N cyclopentane-1,3-dione Chemical compound O=C1CCC(=O)C1 LOGSONSNCYTHPS-UHFFFAOYSA-N 0.000 description 4
- 238000004821 distillation Methods 0.000 description 4
- 238000010828 elution Methods 0.000 description 4
- 150000002148 esters Chemical class 0.000 description 4
- 239000000284 extract Substances 0.000 description 4
- 239000011737 fluorine Substances 0.000 description 4
- 238000007429 general method Methods 0.000 description 4
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 4
- 239000012299 nitrogen atmosphere Substances 0.000 description 4
- 239000000843 powder Substances 0.000 description 4
- 239000012312 sodium hydride Substances 0.000 description 4
- 238000003786 synthesis reaction Methods 0.000 description 4
- VNDYJBBGRKZCSX-UHFFFAOYSA-L zinc bromide Chemical compound Br[Zn]Br VNDYJBBGRKZCSX-UHFFFAOYSA-L 0.000 description 4
- JIAARYAFYJHUJI-UHFFFAOYSA-L zinc dichloride Chemical compound [Cl-].[Cl-].[Zn+2] JIAARYAFYJHUJI-UHFFFAOYSA-L 0.000 description 4
- MUKOFPRVTVYNKX-UHFFFAOYSA-N 5-amino-1-(5-trimethylsilylpent-4-ynyl)pyrazole-4-carbonitrile Chemical compound C[Si](C)(C)C#CCCCN1N=CC(C#N)=C1N MUKOFPRVTVYNKX-UHFFFAOYSA-N 0.000 description 3
- IAYYLAATKYXFCT-UHFFFAOYSA-N 5-amino-1-pent-3-ynylpyrazole-4-carbonitrile Chemical compound CC#CCCN1N=CC(C#N)=C1N IAYYLAATKYXFCT-UHFFFAOYSA-N 0.000 description 3
- FFNKBQRKZRMYCL-UHFFFAOYSA-N 5-amino-1h-pyrazole-4-carbonitrile Chemical compound NC1=NNC=C1C#N FFNKBQRKZRMYCL-UHFFFAOYSA-N 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 3
- 241000282472 Canis lupus familiaris Species 0.000 description 3
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 3
- HFEHLDPGIKPNKL-UHFFFAOYSA-N allyl iodide Chemical compound ICC=C HFEHLDPGIKPNKL-UHFFFAOYSA-N 0.000 description 3
- 239000000908 ammonium hydroxide Substances 0.000 description 3
- 230000036506 anxiety Effects 0.000 description 3
- 230000037396 body weight Effects 0.000 description 3
- 239000003054 catalyst Substances 0.000 description 3
- 125000001309 chloro group Chemical group Cl* 0.000 description 3
- 230000008878 coupling Effects 0.000 description 3
- 238000010168 coupling process Methods 0.000 description 3
- 238000005859 coupling reaction Methods 0.000 description 3
- 239000010779 crude oil Substances 0.000 description 3
- DBOVMTXPZWVYAQ-UHFFFAOYSA-N cycloheptane-1,3-dione Chemical compound O=C1CCCCC(=O)C1 DBOVMTXPZWVYAQ-UHFFFAOYSA-N 0.000 description 3
- 230000035622 drinking Effects 0.000 description 3
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 3
- 230000007062 hydrolysis Effects 0.000 description 3
- 238000006460 hydrolysis reaction Methods 0.000 description 3
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 3
- 235000019341 magnesium sulphate Nutrition 0.000 description 3
- 125000003854 p-chlorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1Cl 0.000 description 3
- 239000012071 phase Substances 0.000 description 3
- 230000004044 response Effects 0.000 description 3
- 238000000926 separation method Methods 0.000 description 3
- 239000007858 starting material Substances 0.000 description 3
- 230000001629 suppression Effects 0.000 description 3
- WSLDOOZREJYCGB-UHFFFAOYSA-N 1,2-Dichloroethane Chemical compound ClCCCl WSLDOOZREJYCGB-UHFFFAOYSA-N 0.000 description 2
- GBHCABUWWQUMAJ-UHFFFAOYSA-N 2-hydrazinoethanol Chemical compound NNCCO GBHCABUWWQUMAJ-UHFFFAOYSA-N 0.000 description 2
- 125000000954 2-hydroxyethyl group Chemical group [H]C([*])([H])C([H])([H])O[H] 0.000 description 2
- JMURNZDCVGWDRG-UHFFFAOYSA-N 3-bromo-1,1-dichloroprop-1-ene Chemical compound ClC(Cl)=CCBr JMURNZDCVGWDRG-UHFFFAOYSA-N 0.000 description 2
- PCTRYMLLRKWXGF-UHFFFAOYSA-N 4-(butylamino)-1-ethyl-6-methyl-5-pyrazolo[3,4-b]pyridinecarboxylic acid ethyl ester Chemical compound CCCCNC1=C(C(=O)OCC)C(C)=NC2=C1C=NN2CC PCTRYMLLRKWXGF-UHFFFAOYSA-N 0.000 description 2
- PKRKJRIVVOGXHM-UHFFFAOYSA-N 4-amino-1h-pyrazole-5-carbonitrile Chemical compound NC=1C=NNC=1C#N PKRKJRIVVOGXHM-UHFFFAOYSA-N 0.000 description 2
- DMAYBPBPEUFIHJ-UHFFFAOYSA-N 4-bromobut-1-ene Chemical compound BrCCC=C DMAYBPBPEUFIHJ-UHFFFAOYSA-N 0.000 description 2
- VUSYNHBKPCGGCI-UHFFFAOYSA-N 4-iodobut-1-ene Chemical compound ICCC=C VUSYNHBKPCGGCI-UHFFFAOYSA-N 0.000 description 2
- BXDJIVKCVVTETR-UHFFFAOYSA-N 4-methylcyclohexane-1,3-dione Chemical compound CC1CCC(=O)CC1=O BXDJIVKCVVTETR-UHFFFAOYSA-N 0.000 description 2
- ASQDYEJRLRENDY-UHFFFAOYSA-N 5-amino-1-(2-chloroethyl)pyrazole-4-carbonitrile Chemical compound NC1=C(C#N)C=NN1CCCl ASQDYEJRLRENDY-UHFFFAOYSA-N 0.000 description 2
- FOZZJAVSCUBGPM-UHFFFAOYSA-N 5-amino-1-(2-hydroxyethyl)pyrazole-4-carbonitrile Chemical compound NC1=C(C#N)C=NN1CCO FOZZJAVSCUBGPM-UHFFFAOYSA-N 0.000 description 2
- SEHFYZRHGUPLSY-UHFFFAOYSA-N 5-iodopent-1-yne Chemical compound ICCCC#C SEHFYZRHGUPLSY-UHFFFAOYSA-N 0.000 description 2
- KZBUYRJDOAKODT-UHFFFAOYSA-N Chlorine Chemical compound ClCl KZBUYRJDOAKODT-UHFFFAOYSA-N 0.000 description 2
- BZKFMUIJRXWWQK-UHFFFAOYSA-N Cyclopentenone Chemical compound O=C1CCC=C1 BZKFMUIJRXWWQK-UHFFFAOYSA-N 0.000 description 2
- OAKJQQAXSVQMHS-UHFFFAOYSA-N Hydrazine Chemical compound NN OAKJQQAXSVQMHS-UHFFFAOYSA-N 0.000 description 2
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
- 241000124008 Mammalia Species 0.000 description 2
- ULHFIFFCDYEZOU-UHFFFAOYSA-N N1=C2N(CCCCC)N=CC2=C(N)C2=C1CC(CC=C)C2=O Chemical compound N1=C2N(CCCCC)N=CC2=C(N)C2=C1CC(CC=C)C2=O ULHFIFFCDYEZOU-UHFFFAOYSA-N 0.000 description 2
- 241000700157 Rattus norvegicus Species 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- 238000000692 Student's t-test Methods 0.000 description 2
- 241000906446 Theraps Species 0.000 description 2
- 238000005903 acid hydrolysis reaction Methods 0.000 description 2
- 150000001350 alkyl halides Chemical class 0.000 description 2
- BHELZAPQIKSEDF-UHFFFAOYSA-N allyl bromide Chemical compound BrCC=C BHELZAPQIKSEDF-UHFFFAOYSA-N 0.000 description 2
- 239000002249 anxiolytic agent Substances 0.000 description 2
- 239000002585 base Substances 0.000 description 2
- 125000003236 benzoyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)=O 0.000 description 2
- 239000000872 buffer Substances 0.000 description 2
- FUSUHKVFWTUUBE-UHFFFAOYSA-N buten-2-one Chemical compound CC(=O)C=C FUSUHKVFWTUUBE-UHFFFAOYSA-N 0.000 description 2
- KMGBZBJJOKUPIA-UHFFFAOYSA-N butyl iodide Chemical compound CCCCI KMGBZBJJOKUPIA-UHFFFAOYSA-N 0.000 description 2
- 229950007168 cartazolate Drugs 0.000 description 2
- 210000003169 central nervous system Anatomy 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 229960004782 chlordiazepoxide Drugs 0.000 description 2
- ANTSCNMPPGJYLG-UHFFFAOYSA-N chlordiazepoxide Chemical compound O=N=1CC(NC)=NC2=CC=C(Cl)C=C2C=1C1=CC=CC=C1 ANTSCNMPPGJYLG-UHFFFAOYSA-N 0.000 description 2
- 238000006114 decarboxylation reaction Methods 0.000 description 2
- RXKJFZQQPQGTFL-UHFFFAOYSA-N dihydroxyacetone Chemical compound OCC(=O)CO RXKJFZQQPQGTFL-UHFFFAOYSA-N 0.000 description 2
- BEPAFCGSDWSTEL-UHFFFAOYSA-N dimethyl malonate Chemical compound COC(=O)CC(=O)OC BEPAFCGSDWSTEL-UHFFFAOYSA-N 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 239000012467 final product Substances 0.000 description 2
- 238000004128 high performance liquid chromatography Methods 0.000 description 2
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 description 2
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 2
- 230000001939 inductive effect Effects 0.000 description 2
- 238000007912 intraperitoneal administration Methods 0.000 description 2
- 125000000468 ketone group Chemical group 0.000 description 2
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 2
- 125000000325 methylidene group Chemical group [H]C([H])=* 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 125000000740 n-pentyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 2
- PVWOIHVRPOBWPI-UHFFFAOYSA-N n-propyl iodide Chemical compound CCCI PVWOIHVRPOBWPI-UHFFFAOYSA-N 0.000 description 2
- 230000003287 optical effect Effects 0.000 description 2
- 239000010502 orange oil Substances 0.000 description 2
- KJIFKLIQANRMOU-UHFFFAOYSA-N oxidanium;4-methylbenzenesulfonate Chemical compound O.CC1=CC=C(S(O)(=O)=O)C=C1 KJIFKLIQANRMOU-UHFFFAOYSA-N 0.000 description 2
- 239000000825 pharmaceutical preparation Substances 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- 150000003217 pyrazoles Chemical class 0.000 description 2
- 230000001624 sedative effect Effects 0.000 description 2
- 235000009518 sodium iodide Nutrition 0.000 description 2
- 239000012258 stirred mixture Substances 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 description 2
- 229950002859 tracazolate Drugs 0.000 description 2
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 description 2
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 2
- 238000005303 weighing Methods 0.000 description 2
- 239000008096 xylene Substances 0.000 description 2
- 229940102001 zinc bromide Drugs 0.000 description 2
- 239000011592 zinc chloride Substances 0.000 description 2
- 235000005074 zinc chloride Nutrition 0.000 description 2
- DNIAPMSPPWPWGF-GSVOUGTGSA-N (R)-(-)-Propylene glycol Chemical compound C[C@@H](O)CO DNIAPMSPPWPWGF-GSVOUGTGSA-N 0.000 description 1
- BNKORGBXOWAMOY-UHFFFAOYSA-N 1,2,3a,4-tetrahydropyrazolo[3,4-b]quinolin-3-one Chemical class C1=CC=C2CC3C(=O)NNC3=NC2=C1 BNKORGBXOWAMOY-UHFFFAOYSA-N 0.000 description 1
- AWNXKZVIZARMME-UHFFFAOYSA-N 1-[[5-[2-[(2-chloropyridin-4-yl)amino]pyrimidin-4-yl]-4-(cyclopropylmethyl)pyrimidin-2-yl]amino]-2-methylpropan-2-ol Chemical compound N=1C(NCC(C)(O)C)=NC=C(C=2N=C(NC=3C=C(Cl)N=CC=3)N=CC=2)C=1CC1CC1 AWNXKZVIZARMME-UHFFFAOYSA-N 0.000 description 1
- BOCZIIQLQJAJND-UHFFFAOYSA-N 1-benzyl-5-[(3-oxocyclohexen-1-yl)amino]pyrazole-4-carbonitrile Chemical compound O=C1CCCC(NC=2N(N=CC=2C#N)CC=2C=CC=CC=2)=C1 BOCZIIQLQJAJND-UHFFFAOYSA-N 0.000 description 1
- LOYZVRIHVZEDMW-UHFFFAOYSA-N 1-bromo-3-methylbut-2-ene Chemical compound CC(C)=CCBr LOYZVRIHVZEDMW-UHFFFAOYSA-N 0.000 description 1
- LNNXOEHOXSYWLD-UHFFFAOYSA-N 1-bromobut-2-yne Chemical compound CC#CCBr LNNXOEHOXSYWLD-UHFFFAOYSA-N 0.000 description 1
- BTUGGGLMQBJCBN-UHFFFAOYSA-N 1-iodo-2-methylpropane Chemical compound CC(C)CI BTUGGGLMQBJCBN-UHFFFAOYSA-N 0.000 description 1
- 238000005160 1H NMR spectroscopy Methods 0.000 description 1
- MBSPVXGYKFWBBE-UHFFFAOYSA-N 1h-pyrazol-5-ylcyanamide Chemical compound N#CNC=1C=CNN=1 MBSPVXGYKFWBBE-UHFFFAOYSA-N 0.000 description 1
- CUMDUXRCTKOWBT-UHFFFAOYSA-N 2,4,5-triazatricyclo[7.5.0.03,7]tetradeca-1,3,7,9,11,13-hexaen-6-one Chemical class C1=CC=CC=C2C=C3C(=O)NN=C3N=C21 CUMDUXRCTKOWBT-UHFFFAOYSA-N 0.000 description 1
- ULSHPDVBNUSTIU-UHFFFAOYSA-N 2,6-dihydro-1h-pyridin-3-one Chemical compound O=C1CNCC=C1 ULSHPDVBNUSTIU-UHFFFAOYSA-N 0.000 description 1
- OEICGMPRFOJHKO-UHFFFAOYSA-N 2-(ethoxymethylidene)propanedinitrile Chemical compound CCOC=C(C#N)C#N OEICGMPRFOJHKO-UHFFFAOYSA-N 0.000 description 1
- HUMUARJXZRKGSF-UHFFFAOYSA-N 3-(2-methylpropoxy)-5-prop-2-enylcyclopent-2-en-1-one Chemical compound CC(C)COC1=CC(=O)C(CC=C)C1 HUMUARJXZRKGSF-UHFFFAOYSA-N 0.000 description 1
- OJEUGDUJEJWIOJ-UHFFFAOYSA-N 3-(2-methylpropoxy)-5-propylcyclopent-2-en-1-one Chemical compound CCCC1CC(OCC(C)C)=CC1=O OJEUGDUJEJWIOJ-UHFFFAOYSA-N 0.000 description 1
- HKJDJRDBJFMDEZ-UHFFFAOYSA-N 3-(2-methylpropoxy)-7-prop-2-enylcyclohept-2-en-1-one Chemical compound CC(C)COC1=CC(=O)C(CC=C)CCC1 HKJDJRDBJFMDEZ-UHFFFAOYSA-N 0.000 description 1
- WRMJZTZUWYMLMD-UHFFFAOYSA-N 3-(2-methylpropoxy)cyclohept-2-en-1-one Chemical compound CC(C)COC1=CC(=O)CCCC1 WRMJZTZUWYMLMD-UHFFFAOYSA-N 0.000 description 1
- JHHZQADGLDKIPM-AATRIKPKSA-N 3-Hepten-2-one Chemical compound CCC\C=C\C(C)=O JHHZQADGLDKIPM-AATRIKPKSA-N 0.000 description 1
- ZCFOBLITZWHNNC-VOTSOKGWSA-N 3-Octen-2-one Chemical compound CCCC\C=C\C(C)=O ZCFOBLITZWHNNC-VOTSOKGWSA-N 0.000 description 1
- AZXRWHWMOLGAFB-UHFFFAOYSA-N 3-amino-1-(5-trimethylsilylpent-4-ynyl)pyrazole-4-carbonitrile Chemical compound C[Si](C)(C)C#CCCCN1C=C(C#N)C(N)=N1 AZXRWHWMOLGAFB-UHFFFAOYSA-N 0.000 description 1
- BVVFCAJIHWZSCT-UHFFFAOYSA-N 3-amino-1-pent-3-ynylpyrazole-4-carbonitrile Chemical compound CC#CCCN1C=C(C#N)C(N)=N1 BVVFCAJIHWZSCT-UHFFFAOYSA-N 0.000 description 1
- SSXRDJNKHTWTGZ-UHFFFAOYSA-N 3-amino-5-[4-(3,3-dichloroprop-2-enyl)-3-oxocyclohexen-1-yl]-1-pentylpyrazole-4-carbonitrile Chemical compound CCCCCN1N=C(N)C(C#N)=C1C1=CC(=O)C(CC=C(Cl)Cl)CC1 SSXRDJNKHTWTGZ-UHFFFAOYSA-N 0.000 description 1
- YSZJXSMTWVQVOW-UHFFFAOYSA-N 3-amino-5-[4-(3,3-dichloroprop-2-enyl)-3-oxocyclopenten-1-yl]-1-pent-3-ynylpyrazole-4-carbonitrile Chemical compound CC#CCCN1N=C(N)C(C#N)=C1C1=CC(=O)C(CC=C(Cl)Cl)C1 YSZJXSMTWVQVOW-UHFFFAOYSA-N 0.000 description 1
- VLVZOBLLQVRDIM-UHFFFAOYSA-N 3-ethoxy-6-(2-methylpropyl)cyclohex-2-en-1-one Chemical compound CCOC1=CC(=O)C(CC(C)C)CC1 VLVZOBLLQVRDIM-UHFFFAOYSA-N 0.000 description 1
- DHPBAKUCKTZWTD-UHFFFAOYSA-N 3-ethoxy-6-(3-methylbut-2-enyl)cyclohex-2-en-1-one Chemical compound CCOC1=CC(=O)C(CC=C(C)C)CC1 DHPBAKUCKTZWTD-UHFFFAOYSA-N 0.000 description 1
- MDJANMQJJAAFGW-UHFFFAOYSA-N 3-ethoxy-6-ethylcyclohex-2-en-1-one Chemical compound CCOC1=CC(=O)C(CC)CC1 MDJANMQJJAAFGW-UHFFFAOYSA-N 0.000 description 1
- LVCINSLLJIHISO-UHFFFAOYSA-N 3-ethoxy-6-methylcyclohex-2-en-1-one Chemical compound CCOC1=CC(=O)C(C)CC1 LVCINSLLJIHISO-UHFFFAOYSA-N 0.000 description 1
- FNWFIISKDUVQCW-UHFFFAOYSA-N 3-ethoxy-6-prop-2-enylcyclohex-2-en-1-one Chemical compound CCOC1=CC(=O)C(CC=C)CC1 FNWFIISKDUVQCW-UHFFFAOYSA-N 0.000 description 1
- LASOUINACJYUTE-UHFFFAOYSA-N 3-ethoxy-6-propan-2-ylcyclohex-2-en-1-one Chemical compound CCOC1=CC(=O)C(C(C)C)CC1 LASOUINACJYUTE-UHFFFAOYSA-N 0.000 description 1
- HYMNYJDADNTSIS-UHFFFAOYSA-N 3-ethoxy-6-propylcyclohex-2-en-1-one Chemical compound CCCC1CCC(OCC)=CC1=O HYMNYJDADNTSIS-UHFFFAOYSA-N 0.000 description 1
- URKXGIXFPYIONB-UHFFFAOYSA-N 3-propylcyclohexane-1,2-dione Chemical compound CCCC1CCCC(=O)C1=O URKXGIXFPYIONB-UHFFFAOYSA-N 0.000 description 1
- VBBOTNFXUMPCFP-UHFFFAOYSA-N 4,4-dimethylcyclopentane-1,3-dione Chemical compound CC1(C)CC(=O)CC1=O VBBOTNFXUMPCFP-UHFFFAOYSA-N 0.000 description 1
- OUCAIBFEZQHXJQ-UHFFFAOYSA-N 4,5-dimethyl-3-(2-methylpropoxy)cyclopent-2-en-1-one Chemical compound CC(C)COC1=CC(=O)C(C)C1C OUCAIBFEZQHXJQ-UHFFFAOYSA-N 0.000 description 1
- BEGWHAMZTVHPHZ-UHFFFAOYSA-N 4,5-dimethylcyclopentane-1,3-dione Chemical compound CC1C(C)C(=O)CC1=O BEGWHAMZTVHPHZ-UHFFFAOYSA-N 0.000 description 1
- WOBXHPUNASCJQC-UHFFFAOYSA-N 4-(2-methylpropyl)cyclohexane-1,3-dione Chemical compound CC(C)CC1CCC(=O)CC1=O WOBXHPUNASCJQC-UHFFFAOYSA-N 0.000 description 1
- JBUOGNUEBCXSBU-UHFFFAOYSA-N 4-(3,3-dichloroprop-2-enyl)cyclohexane-1,3-dione Chemical compound ClC(Cl)=CCC1CCC(=O)CC1=O JBUOGNUEBCXSBU-UHFFFAOYSA-N 0.000 description 1
- KXLQRFPYLYJRCD-UHFFFAOYSA-N 4-(3,3-dichloroprop-2-enyl)cyclopentane-1,3-dione Chemical compound ClC(Cl)=CCC1CC(=O)CC1=O KXLQRFPYLYJRCD-UHFFFAOYSA-N 0.000 description 1
- LWEBUQVECDQRCX-UHFFFAOYSA-N 4-(3-methylbut-2-enyl)cyclohexane-1,3-dione Chemical compound CC(C)=CCC1CCC(=O)CC1=O LWEBUQVECDQRCX-UHFFFAOYSA-N 0.000 description 1
- CSDQQAQKBAQLLE-UHFFFAOYSA-N 4-(4-chlorophenyl)-4,5,6,7-tetrahydrothieno[3,2-c]pyridine Chemical compound C1=CC(Cl)=CC=C1C1C(C=CS2)=C2CCN1 CSDQQAQKBAQLLE-UHFFFAOYSA-N 0.000 description 1
- QCQCHGYLTSGIGX-GHXANHINSA-N 4-[[(3ar,5ar,5br,7ar,9s,11ar,11br,13as)-5a,5b,8,8,11a-pentamethyl-3a-[(5-methylpyridine-3-carbonyl)amino]-2-oxo-1-propan-2-yl-4,5,6,7,7a,9,10,11,11b,12,13,13a-dodecahydro-3h-cyclopenta[a]chrysen-9-yl]oxy]-2,2-dimethyl-4-oxobutanoic acid Chemical compound N([C@@]12CC[C@@]3(C)[C@]4(C)CC[C@H]5C(C)(C)[C@@H](OC(=O)CC(C)(C)C(O)=O)CC[C@]5(C)[C@H]4CC[C@@H]3C1=C(C(C2)=O)C(C)C)C(=O)C1=CN=CC(C)=C1 QCQCHGYLTSGIGX-GHXANHINSA-N 0.000 description 1
- MWKUZDQNPHIKKD-UHFFFAOYSA-N 4-benzylcyclohexane-1,3-dione Chemical compound O=C1CC(=O)CCC1CC1=CC=CC=C1 MWKUZDQNPHIKKD-UHFFFAOYSA-N 0.000 description 1
- CETANBPPPSSDTB-UHFFFAOYSA-N 4-but-2-ynylcyclohexane-1,3-dione Chemical compound CC#CCC1CCC(=O)CC1=O CETANBPPPSSDTB-UHFFFAOYSA-N 0.000 description 1
- FHMNKGYIJJPTSJ-UHFFFAOYSA-N 4-but-3-enylcyclopentane-1,3-dione Chemical compound C=CCCC1CC(=O)CC1=O FHMNKGYIJJPTSJ-UHFFFAOYSA-N 0.000 description 1
- CIGRDIKSDXUPHG-UHFFFAOYSA-N 4-butylcyclohexane-1,3-dione Chemical compound CCCCC1CCC(=O)CC1=O CIGRDIKSDXUPHG-UHFFFAOYSA-N 0.000 description 1
- XXNOGQJZAOXWAQ-UHFFFAOYSA-N 4-chlorophenylhydrazine Chemical compound NNC1=CC=C(Cl)C=C1 XXNOGQJZAOXWAQ-UHFFFAOYSA-N 0.000 description 1
- IDESFDLCRXUSGK-UHFFFAOYSA-N 4-ethylcyclohexane-1,3-dione Chemical compound CCC1CCC(=O)CC1=O IDESFDLCRXUSGK-UHFFFAOYSA-N 0.000 description 1
- GXLHXLFBLQXKMP-UHFFFAOYSA-N 4-ethylcyclopentane-1,3-dione Chemical compound CCC1CC(=O)CC1=O GXLHXLFBLQXKMP-UHFFFAOYSA-N 0.000 description 1
- PZLUHOIVGBWDBW-UHFFFAOYSA-N 4-phenylcyclohexane-1,3-dione Chemical compound O=C1CC(=O)CCC1C1=CC=CC=C1 PZLUHOIVGBWDBW-UHFFFAOYSA-N 0.000 description 1
- XBQHLHKTSPWYGD-UHFFFAOYSA-N 4-prop-2-enylcycloheptane-1,3-dione Chemical compound C=CCC1CCCC(=O)CC1=O XBQHLHKTSPWYGD-UHFFFAOYSA-N 0.000 description 1
- QYRCMTCDSZFQHQ-UHFFFAOYSA-N 4-prop-2-enylcyclohexane-1,3-dione Chemical compound C=CCC1CCC(=O)CC1=O QYRCMTCDSZFQHQ-UHFFFAOYSA-N 0.000 description 1
- NOONIXPOHUYFGS-UHFFFAOYSA-N 4-prop-2-enylcyclopentane-1,3-dione Chemical compound C=CCC1CC(=O)CC1=O NOONIXPOHUYFGS-UHFFFAOYSA-N 0.000 description 1
- IBNLVXNNYIGLLB-UHFFFAOYSA-N 4-propan-2-ylcyclohexane-1,3-dione Chemical compound CC(C)C1CCC(=O)CC1=O IBNLVXNNYIGLLB-UHFFFAOYSA-N 0.000 description 1
- WWLVJBISOZBFCG-UHFFFAOYSA-N 4-propylcyclohexane-1,3-dione Chemical compound CCCC1CCC(=O)CC1=O WWLVJBISOZBFCG-UHFFFAOYSA-N 0.000 description 1
- QTPCICZFFUJLGF-UHFFFAOYSA-N 4-propylcyclopentane-1,3-dione Chemical compound CCCC1CC(=O)CC1=O QTPCICZFFUJLGF-UHFFFAOYSA-N 0.000 description 1
- DRMAXCYEPWKBOQ-UHFFFAOYSA-N 5,5-dimethyl-3-(2-methylpropoxy)cyclopent-2-en-1-one Chemical compound CC(C)COC1=CC(=O)C(C)(C)C1 DRMAXCYEPWKBOQ-UHFFFAOYSA-N 0.000 description 1
- UAKHLNXSLFZIBG-UHFFFAOYSA-N 5-(3,3-dichloroprop-2-enyl)-3-(2-methylpropoxy)cyclopent-2-en-1-one Chemical compound CC(C)COC1=CC(=O)C(CC=C(Cl)Cl)C1 UAKHLNXSLFZIBG-UHFFFAOYSA-N 0.000 description 1
- KWSKDGKCPJUWCQ-UHFFFAOYSA-N 5-[(3-oxo-4-phenylcyclohexen-1-yl)amino]-1-pentylpyrazole-4-carbonitrile Chemical compound CCCCCN1N=CC(C#N)=C1NC1=CC(=O)C(C=2C=CC=CC=2)CC1 KWSKDGKCPJUWCQ-UHFFFAOYSA-N 0.000 description 1
- ATESGGJSXCERQY-UHFFFAOYSA-N 5-[(3-oxo-4-propylcyclohexen-1-yl)amino]-1-pentylpyrazole-4-carbonitrile Chemical compound CCCCCN1N=CC(C#N)=C1NC1=CC(=O)C(CCC)CC1 ATESGGJSXCERQY-UHFFFAOYSA-N 0.000 description 1
- ZWMFLYYNYBBIAF-UHFFFAOYSA-N 5-[(3-oxo-4-propylcyclopenten-1-yl)amino]-1-pentylpyrazole-4-carbonitrile Chemical compound CCCCCN1N=CC(C#N)=C1NC1=CC(=O)C(CCC)C1 ZWMFLYYNYBBIAF-UHFFFAOYSA-N 0.000 description 1
- YSQJRSIXVABYEH-UHFFFAOYSA-N 5-[(3-oxocyclohepten-1-yl)amino]-1-pentylpyrazole-4-carbonitrile Chemical compound CCCCCN1N=CC(C#N)=C1NC1=CC(=O)CCCC1 YSQJRSIXVABYEH-UHFFFAOYSA-N 0.000 description 1
- PVPDKVSBYMSHDL-UHFFFAOYSA-N 5-[(3-oxocyclohexen-1-yl)amino]-1-pentylpyrazole-4-carbonitrile Chemical compound CCCCCN1N=CC(C#N)=C1NC1=CC(=O)CCC1 PVPDKVSBYMSHDL-UHFFFAOYSA-N 0.000 description 1
- AXNNXGNWHXINKN-UHFFFAOYSA-N 5-[(3-oxocyclopenten-1-yl)amino]-1-pentylpyrazole-4-carbonitrile Chemical compound CCCCCN1N=CC(C#N)=C1NC1=CC(=O)CC1 AXNNXGNWHXINKN-UHFFFAOYSA-N 0.000 description 1
- QFFWACVYWGOQSW-UHFFFAOYSA-N 5-[(4-but-3-enyl-3-oxocyclopenten-1-yl)amino]-1-pentylpyrazole-4-carbonitrile Chemical compound CCCCCN1N=CC(C#N)=C1NC1=CC(=O)C(CCC=C)C1 QFFWACVYWGOQSW-UHFFFAOYSA-N 0.000 description 1
- JDIDQWAVRWHZCU-UHFFFAOYSA-N 5-[(4-butyl-3-oxocyclohexen-1-yl)amino]-1-pentylpyrazole-4-carbonitrile Chemical compound CCCCCN1N=CC(C#N)=C1NC1=CC(=O)C(CCCC)CC1 JDIDQWAVRWHZCU-UHFFFAOYSA-N 0.000 description 1
- JJXDOMLRLQDKFN-UHFFFAOYSA-N 5-[(4-ethyl-3-oxocyclohexen-1-yl)amino]-1-pentylpyrazole-4-carbonitrile Chemical compound CCCCCN1N=CC(C#N)=C1NC1=CC(=O)C(CC)CC1 JJXDOMLRLQDKFN-UHFFFAOYSA-N 0.000 description 1
- IURFIDOFCXVESE-UHFFFAOYSA-N 5-[(4-methyl-3-oxocyclohexen-1-yl)amino]-1-pentylpyrazole-4-carbonitrile Chemical compound CCCCCN1N=CC(C#N)=C1NC1=CC(=O)C(C)CC1 IURFIDOFCXVESE-UHFFFAOYSA-N 0.000 description 1
- NBLINTAXPOAIIU-UHFFFAOYSA-N 5-[(4-methyl-3-oxocyclopenten-1-yl)amino]-1-pentylpyrazole-4-carbonitrile Chemical compound CCCCCN1N=CC(C#N)=C1NC1=CC(=O)C(C)C1 NBLINTAXPOAIIU-UHFFFAOYSA-N 0.000 description 1
- DKAVJMIMKFXZEO-UHFFFAOYSA-N 5-[(5-butyl-3-oxocyclohexen-1-yl)amino]-1-pentylpyrazole-4-carbonitrile Chemical compound CCCCCN1N=CC(C#N)=C1NC1=CC(=O)CC(CCCC)C1 DKAVJMIMKFXZEO-UHFFFAOYSA-N 0.000 description 1
- WIWSALMJHPGFDY-UHFFFAOYSA-N 5-amino-1-(4-chlorophenyl)-1h-pyrazole-4-carbonitrile Chemical compound NC1=C(C#N)C=NN1C1=CC=C(Cl)C=C1 WIWSALMJHPGFDY-UHFFFAOYSA-N 0.000 description 1
- GAVXFBPVQOBHDS-UHFFFAOYSA-N 5-amino-1-benzylpyrazole-4-carbonitrile Chemical compound NC1=C(C#N)C=NN1CC1=CC=CC=C1 GAVXFBPVQOBHDS-UHFFFAOYSA-N 0.000 description 1
- GSWDIGMRMLMABI-UHFFFAOYSA-N 5-amino-1-pentylpyrazole-4-carbonitrile Chemical compound CCCCCN1N=CC(C#N)=C1N GSWDIGMRMLMABI-UHFFFAOYSA-N 0.000 description 1
- LMOYJSTVAJFQKE-UHFFFAOYSA-N 5-but-3-enyl-3-(2-methylpropoxy)cyclopent-2-en-1-one Chemical compound CC(C)COC1=CC(=O)C(CCC=C)C1 LMOYJSTVAJFQKE-UHFFFAOYSA-N 0.000 description 1
- XYCGRKZASIFMJX-UHFFFAOYSA-N 5-butylcyclohexane-1,3-dione Chemical compound CCCCC1CC(=O)CC(=O)C1 XYCGRKZASIFMJX-UHFFFAOYSA-N 0.000 description 1
- WTMGKWFVFLUFMD-UHFFFAOYSA-N 5-ethyl-3-(2-methylpropoxy)cyclopent-2-en-1-one Chemical compound CCC1CC(OCC(C)C)=CC1=O WTMGKWFVFLUFMD-UHFFFAOYSA-N 0.000 description 1
- MWSACCMIYLPDDZ-UHFFFAOYSA-N 5-iodopent-1-ynyl(trimethyl)silane Chemical compound C[Si](C)(C)C#CCCCI MWSACCMIYLPDDZ-UHFFFAOYSA-N 0.000 description 1
- FZSKIOXQLHOWCI-UHFFFAOYSA-N 5-methyl-3-(2-methylpropoxy)cyclopent-2-en-1-one Chemical compound CC(C)COC1=CC(=O)C(C)C1 FZSKIOXQLHOWCI-UHFFFAOYSA-N 0.000 description 1
- RHELOIKNLIFWEO-UHFFFAOYSA-N 5-propylcyclohexane-1,3-dione Chemical compound CCCC1CC(=O)CC(=O)C1 RHELOIKNLIFWEO-UHFFFAOYSA-N 0.000 description 1
- PGERAVPJZLDYIL-UHFFFAOYSA-N 6-(3,3-dichloroprop-2-enyl)-3-ethoxycyclohex-2-en-1-one Chemical compound CCOC1=CC(=O)C(CC=C(Cl)Cl)CC1 PGERAVPJZLDYIL-UHFFFAOYSA-N 0.000 description 1
- LSNWAPKEMOFCEU-UHFFFAOYSA-N 6-benzyl-3-ethoxycyclohex-2-en-1-one Chemical compound C1CC(OCC)=CC(=O)C1CC1=CC=CC=C1 LSNWAPKEMOFCEU-UHFFFAOYSA-N 0.000 description 1
- JNAMITDVSNLXBU-UHFFFAOYSA-N 6-but-2-ynyl-3-ethoxycyclohex-2-en-1-one Chemical compound CCOC1=CC(=O)C(CC#CC)CC1 JNAMITDVSNLXBU-UHFFFAOYSA-N 0.000 description 1
- BZXMXADDNQRJBG-UHFFFAOYSA-N 6-but-3-enyl-3-ethoxycyclohex-2-en-1-one Chemical compound CCOC1=CC(=O)C(CCC=C)CC1 BZXMXADDNQRJBG-UHFFFAOYSA-N 0.000 description 1
- KNEFBIFMLFLOOE-UHFFFAOYSA-N 6-butyl-3-ethoxycyclohex-2-en-1-one Chemical compound CCCCC1CCC(OCC)=CC1=O KNEFBIFMLFLOOE-UHFFFAOYSA-N 0.000 description 1
- NNNOHBBOFIFCCL-UHFFFAOYSA-N 6-methylcyclohex-2-en-1-one Chemical compound CC1CCC=CC1=O NNNOHBBOFIFCCL-UHFFFAOYSA-N 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- VXKLRYOZRJZWLL-UHFFFAOYSA-N 8-(butylamino)-4-pentyl-11-prop-2-enyl-2,4,5-triazatricyclo[7.3.0.03,7]dodeca-1(9),2,5,7-tetraen-10-one Chemical compound N1=C2N(CCCCC)N=CC2=C(NCCCC)C2=C1CC(CC=C)C2=O VXKLRYOZRJZWLL-UHFFFAOYSA-N 0.000 description 1
- PZASAAIJIFDWSB-CKPDSHCKSA-N 8-[(1S)-1-[8-(trifluoromethyl)-7-[4-(trifluoromethyl)cyclohexyl]oxynaphthalen-2-yl]ethyl]-8-azabicyclo[3.2.1]octane-3-carboxylic acid Chemical compound FC(F)(F)C=1C2=CC([C@@H](N3C4CCC3CC(C4)C(O)=O)C)=CC=C2C=CC=1OC1CCC(C(F)(F)F)CC1 PZASAAIJIFDWSB-CKPDSHCKSA-N 0.000 description 1
- XWJNKADUESRUHO-UHFFFAOYSA-N 8-amino-11,12-dimethyl-4-pentyl-2,4,5-triazatricyclo[7.3.0.03,7]dodeca-1(9),2,5,7-tetraen-10-one Chemical compound N1=C2N(CCCCC)N=CC2=C(N)C2=C1C(C)C(C)C2=O XWJNKADUESRUHO-UHFFFAOYSA-N 0.000 description 1
- NSPFGJNZAFRHLU-UHFFFAOYSA-N 8-amino-11-(3,3-dichloroprop-2-enyl)-4-pent-3-ynyl-2,4,5-triazatricyclo[7.3.0.03,7]dodeca-1(9),2,5,7-tetraen-10-one Chemical compound N1=C2N(CCC#CC)N=CC2=C(N)C2=C1CC(CC=C(Cl)Cl)C2=O NSPFGJNZAFRHLU-UHFFFAOYSA-N 0.000 description 1
- YFJAFKXKPYJWDN-UHFFFAOYSA-N 8-amino-11-(3,3-dichloroprop-2-enyl)-4-pentyl-2,4,5-triazatricyclo[7.3.0.03,7]dodeca-1(9),2,5,7-tetraen-10-one Chemical compound N1=C2N(CCCCC)N=CC2=C(N)C2=C1CC(CC=C(Cl)Cl)C2=O YFJAFKXKPYJWDN-UHFFFAOYSA-N 0.000 description 1
- VJIYETIANDQWFO-UHFFFAOYSA-N 8-amino-11-but-3-enyl-4-pentyl-2,4,5-triazatricyclo[7.3.0.03,7]dodeca-1(9),2,5,7-tetraen-10-one Chemical compound N1=C2N(CCCCC)N=CC2=C(N)C2=C1CC(CCC=C)C2=O VJIYETIANDQWFO-UHFFFAOYSA-N 0.000 description 1
- NTYAWXUUHKFMNR-UHFFFAOYSA-N 8-amino-4-pent-4-ynyl-11-prop-2-enyl-2,4,5-triazatricyclo[7.3.0.03,7]dodeca-1(9),2,5,7-tetraen-10-one Chemical compound NC1=C2C(=O)C(CC=C)CC2=NC2=C1C=NN2CCCC#C NTYAWXUUHKFMNR-UHFFFAOYSA-N 0.000 description 1
- RQQAAJAFSQCJOZ-UHFFFAOYSA-N 8-amino-4-pentyl-11-prop-2-enyl-2,4,5-triazatricyclo[7.5.0.03,7]tetradeca-1(9),2,5,7,13-pentaen-10-one Chemical compound N1=C2N(CCCCC)N=CC2=C(N)C2=C1C=CCC(CC=C)C2=O RQQAAJAFSQCJOZ-UHFFFAOYSA-N 0.000 description 1
- AWOWYBRIWHHSLK-UHFFFAOYSA-N 8-amino-4-pentyl-12-prop-2-enyl-2,4,5-triazatricyclo[7.3.0.03,7]dodeca-1(9),2,5,7-tetraen-10-one Chemical compound N1=C2N(CCCCC)N=CC2=C(N)C2=C1C(CC=C)CC2=O AWOWYBRIWHHSLK-UHFFFAOYSA-N 0.000 description 1
- HVZVFRUGFBDOEK-UHFFFAOYSA-N 8-amino-4-pentyl-2,4,5-triazatricyclo[7.5.0.03,7]tetradeca-1(9),2,5,7,13-pentaen-10-one Chemical compound N1=C2N(CCCCC)N=CC2=C(N)C2=C1C=CCCC2=O HVZVFRUGFBDOEK-UHFFFAOYSA-N 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 1
- 101100347605 Arabidopsis thaliana VIII-A gene Proteins 0.000 description 1
- 206010003591 Ataxia Diseases 0.000 description 1
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 1
- ZTQSAGDEMFDKMZ-UHFFFAOYSA-N Butyraldehyde Chemical compound CCCC=O ZTQSAGDEMFDKMZ-UHFFFAOYSA-N 0.000 description 1
- 101150041968 CDC13 gene Proteins 0.000 description 1
- 101100219382 Caenorhabditis elegans cah-2 gene Proteins 0.000 description 1
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- ZGTMUACCHSMWAC-UHFFFAOYSA-L EDTA disodium salt (anhydrous) Chemical compound [Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC(O)=O)CC([O-])=O ZGTMUACCHSMWAC-UHFFFAOYSA-L 0.000 description 1
- IYXGSMUGOJNHAZ-UHFFFAOYSA-N Ethyl malonate Chemical class CCOC(=O)CC(=O)OCC IYXGSMUGOJNHAZ-UHFFFAOYSA-N 0.000 description 1
- 241000282326 Felis catus Species 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- CPELXLSAUQHCOX-UHFFFAOYSA-N Hydrogen bromide Chemical class Br CPELXLSAUQHCOX-UHFFFAOYSA-N 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 229930194542 Keto Natural products 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- HSHXDCVZWHOWCS-UHFFFAOYSA-N N'-hexadecylthiophene-2-carbohydrazide Chemical compound CCCCCCCCCCCCCCCCNNC(=O)c1cccs1 HSHXDCVZWHOWCS-UHFFFAOYSA-N 0.000 description 1
- VTMODOGRFDZJHC-UHFFFAOYSA-N N1=C2C=CC=C2C=C2C(=O)NN=C21 Chemical class N1=C2C=CC=C2C=C2C(=O)NN=C21 VTMODOGRFDZJHC-UHFFFAOYSA-N 0.000 description 1
- WPFVZKZNOSIYJT-UHFFFAOYSA-N N1=C2N(CCCCC)N=CC2=C(N)C2=C1CCC2=O Chemical compound N1=C2N(CCCCC)N=CC2=C(N)C2=C1CCC2=O WPFVZKZNOSIYJT-UHFFFAOYSA-N 0.000 description 1
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 1
- 235000019502 Orange oil Nutrition 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
- ATJFFYVFTNAWJD-UHFFFAOYSA-N Tin Chemical compound [Sn] ATJFFYVFTNAWJD-UHFFFAOYSA-N 0.000 description 1
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 230000029936 alkylation Effects 0.000 description 1
- 238000005804 alkylation reaction Methods 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000000049 anti-anxiety effect Effects 0.000 description 1
- 230000001253 anti-conflict Effects 0.000 description 1
- 229940005530 anxiolytics Drugs 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 229940049706 benzodiazepine Drugs 0.000 description 1
- 150000001557 benzodiazepines Chemical class 0.000 description 1
- KCXMKQUNVWSEMD-UHFFFAOYSA-N benzyl chloride Chemical compound ClCC1=CC=CC=C1 KCXMKQUNVWSEMD-UHFFFAOYSA-N 0.000 description 1
- 229940073608 benzyl chloride Drugs 0.000 description 1
- NHOWLEZFTHYCTP-UHFFFAOYSA-N benzylhydrazine Chemical compound NNCC1=CC=CC=C1 NHOWLEZFTHYCTP-UHFFFAOYSA-N 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 1
- 229910052794 bromium Inorganic materials 0.000 description 1
- 230000005587 bubbling Effects 0.000 description 1
- 125000004063 butyryl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 235000011089 carbon dioxide Nutrition 0.000 description 1
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- IQNQAOGGWGCROX-UHFFFAOYSA-N cartazolate Chemical compound CCCCNC1=C(C(=O)OCC)C=NC2=C1C=NN2CC IQNQAOGGWGCROX-UHFFFAOYSA-N 0.000 description 1
- 239000003874 central nervous system depressant Substances 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 238000000451 chemical ionisation Methods 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- DGBIGWXXNGSACT-UHFFFAOYSA-N clonazepam Chemical compound C12=CC([N+](=O)[O-])=CC=C2NC(=O)CN=C1C1=CC=CC=C1Cl DGBIGWXXNGSACT-UHFFFAOYSA-N 0.000 description 1
- 229960003120 clonazepam Drugs 0.000 description 1
- 238000004891 communication Methods 0.000 description 1
- 238000009833 condensation Methods 0.000 description 1
- 230000005494 condensation Effects 0.000 description 1
- 238000006482 condensation reaction Methods 0.000 description 1
- 230000036461 convulsion Effects 0.000 description 1
- OPQARKPSCNTWTJ-UHFFFAOYSA-L copper(ii) acetate Chemical compound [Cu+2].CC([O-])=O.CC([O-])=O OPQARKPSCNTWTJ-UHFFFAOYSA-L 0.000 description 1
- WZCRDVTWUYLPTR-UHFFFAOYSA-N cyclohept-2-en-1-one Chemical compound O=C1CCCCC=C1 WZCRDVTWUYLPTR-UHFFFAOYSA-N 0.000 description 1
- FWFSEYBSWVRWGL-UHFFFAOYSA-N cyclohex-2-enone Chemical compound O=C1CCCC=C1 FWFSEYBSWVRWGL-UHFFFAOYSA-N 0.000 description 1
- 238000006704 dehydrohalogenation reaction Methods 0.000 description 1
- 230000000994 depressogenic effect Effects 0.000 description 1
- 229960003529 diazepam Drugs 0.000 description 1
- AAOVKJBEBIDNHE-UHFFFAOYSA-N diazepam Chemical compound N=1CC(=O)N(C)C2=CC=C(Cl)C=C2C=1C1=CC=CC=C1 AAOVKJBEBIDNHE-UHFFFAOYSA-N 0.000 description 1
- FGYDHYCFHBSNPE-UHFFFAOYSA-N diethyl phenylmalonate Chemical compound CCOC(=O)C(C(=O)OCC)C1=CC=CC=C1 FGYDHYCFHBSNPE-UHFFFAOYSA-N 0.000 description 1
- 238000006073 displacement reaction Methods 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 238000001647 drug administration Methods 0.000 description 1
- 125000002587 enol group Chemical group 0.000 description 1
- 239000012259 ether extract Substances 0.000 description 1
- MQCMELRHAPCCCW-UHFFFAOYSA-N ethyl 2,4-dioxo-1-phenylcyclohexane-1-carboxylate Chemical compound C=1C=CC=CC=1C1(C(=O)OCC)CCC(=O)CC1=O MQCMELRHAPCCCW-UHFFFAOYSA-N 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000011888 foil Substances 0.000 description 1
- 238000001640 fractional crystallisation Methods 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 238000003304 gavage Methods 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 150000004820 halides Chemical class 0.000 description 1
- 239000008241 heterogeneous mixture Substances 0.000 description 1
- MWVFCEVNXHTDNF-UHFFFAOYSA-N hexane-2,3-dione Chemical class CCCC(=O)C(C)=O MWVFCEVNXHTDNF-UHFFFAOYSA-N 0.000 description 1
- 150000003840 hydrochlorides Chemical class 0.000 description 1
- XMBWDFGMSWQBCA-UHFFFAOYSA-N hydrogen iodide Chemical compound I XMBWDFGMSWQBCA-UHFFFAOYSA-N 0.000 description 1
- 230000003301 hydrolyzing effect Effects 0.000 description 1
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 239000012442 inert solvent Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- FMKOJHQHASLBPH-UHFFFAOYSA-N isopropyl iodide Chemical compound CC(C)I FMKOJHQHASLBPH-UHFFFAOYSA-N 0.000 description 1
- 239000011968 lewis acid catalyst Substances 0.000 description 1
- 229910052744 lithium Inorganic materials 0.000 description 1
- 238000010907 mechanical stirring Methods 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- HZVOZRGWRWCICA-UHFFFAOYSA-N methanediyl Chemical compound [CH2] HZVOZRGWRWCICA-UHFFFAOYSA-N 0.000 description 1
- AFVFQIVMOAPDHO-UHFFFAOYSA-M methanesulfonate group Chemical class CS(=O)(=O)[O-] AFVFQIVMOAPDHO-UHFFFAOYSA-M 0.000 description 1
- IAAKJUUAGLROPG-UHFFFAOYSA-N methyl 2,4-dioxo-6-propylcyclohexane-1-carboxylate Chemical compound CCCC1CC(=O)CC(=O)C1C(=O)OC IAAKJUUAGLROPG-UHFFFAOYSA-N 0.000 description 1
- KMAXUCMBPAKSSH-UHFFFAOYSA-N methyl 2-butyl-4,6-dioxocyclohexane-1-carboxylate Chemical compound CCCCC1CC(=O)CC(=O)C1C(=O)OC KMAXUCMBPAKSSH-UHFFFAOYSA-N 0.000 description 1
- ZGEGCLOFRBLKSE-UHFFFAOYSA-N methylene hexane Natural products CCCCCC=C ZGEGCLOFRBLKSE-UHFFFAOYSA-N 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 230000037023 motor activity Effects 0.000 description 1
- 210000002445 nipple Anatomy 0.000 description 1
- 150000002823 nitrates Chemical class 0.000 description 1
- 230000009871 nonspecific binding Effects 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 239000004533 oil dispersion Substances 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 239000012044 organic layer Substances 0.000 description 1
- HGBOYTHUEUWSSQ-UHFFFAOYSA-N pentanal Chemical compound CCCCC=O HGBOYTHUEUWSSQ-UHFFFAOYSA-N 0.000 description 1
- YVZACCLFRNQBNO-UHFFFAOYSA-N pentylhydrazine Chemical compound CCCCCNN YVZACCLFRNQBNO-UHFFFAOYSA-N 0.000 description 1
- 125000005981 pentynyl group Chemical group 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 125000003884 phenylalkyl group Chemical group 0.000 description 1
- 235000021317 phosphate Nutrition 0.000 description 1
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 239000013641 positive control Substances 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 125000001325 propanoyl group Chemical group O=C([*])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000004368 propenyl group Chemical group C(=CC)* 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 239000013014 purified material Substances 0.000 description 1
- QANTYHOXOWSHBO-UHFFFAOYSA-N pyrazolo[3,4-b]quinolin-5-one Chemical compound N1=C2N=NC=C2C=C2C(=O)C=CC=C21 QANTYHOXOWSHBO-UHFFFAOYSA-N 0.000 description 1
- 150000005229 pyrazolopyridines Chemical class 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000012501 relaxation of skeletal muscle Effects 0.000 description 1
- 102220264750 rs1305455942 Human genes 0.000 description 1
- 102220095236 rs876658436 Human genes 0.000 description 1
- 239000012266 salt solution Substances 0.000 description 1
- 231100000161 signs of toxicity Toxicity 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 235000017550 sodium carbonate Nutrition 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 229910052938 sodium sulfate Inorganic materials 0.000 description 1
- 235000011152 sodium sulphate Nutrition 0.000 description 1
- 210000000278 spinal cord Anatomy 0.000 description 1
- 238000013222 sprague-dawley male rat Methods 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 150000003467 sulfuric acid derivatives Chemical class 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- CZDYPVPMEAXLPK-UHFFFAOYSA-N tetramethylsilane Chemical compound C[Si](C)(C)C CZDYPVPMEAXLPK-UHFFFAOYSA-N 0.000 description 1
- 238000011287 therapeutic dose Methods 0.000 description 1
- 238000004809 thin layer chromatography Methods 0.000 description 1
- JHHZQADGLDKIPM-UHFFFAOYSA-N trans-hept-3-en-2-one Natural products CCCC=CC(C)=O JHHZQADGLDKIPM-UHFFFAOYSA-N 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 150000003738 xylenes Chemical class 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D231/38—Nitrogen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C403/00—Derivatives of cyclohexane or of a cyclohexene or of cyclohexadiene, having a side-chain containing an acyclic unsaturated part of at least four carbon atoms, this part being directly attached to the cyclohexane or cyclohexene or cyclohexadiene rings, e.g. vitamin A, beta-carotene, beta-ionone
- C07C403/02—Derivatives of cyclohexane or of a cyclohexene or of cyclohexadiene, having a side-chain containing an acyclic unsaturated part of at least four carbon atoms, this part being directly attached to the cyclohexane or cyclohexene or cyclohexadiene rings, e.g. vitamin A, beta-carotene, beta-ionone having side-chains containing only carbon and hydrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
- C07C45/51—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by pyrolysis, rearrangement or decomposition
- C07C45/511—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by pyrolysis, rearrangement or decomposition involving transformation of singly bound oxygen functional groups to >C = O groups
- C07C45/513—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by pyrolysis, rearrangement or decomposition involving transformation of singly bound oxygen functional groups to >C = O groups the singly bound functional group being an etherified hydroxyl group
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
- C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
- C07C45/67—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
- C07C45/673—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by change of size of the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
- C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
- C07C45/67—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
- C07C45/673—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by change of size of the carbon skeleton
- C07C45/676—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by change of size of the carbon skeleton by elimination of carboxyl groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
- C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
- C07C45/67—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
- C07C45/68—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
- C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
- C07C45/67—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
- C07C45/68—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms
- C07C45/70—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction with functional groups containing oxygen only in singly bound form
- C07C45/71—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction with functional groups containing oxygen only in singly bound form being hydroxy groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
- C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
- C07C45/67—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
- C07C45/68—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms
- C07C45/72—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction of compounds containing >C = O groups with the same or other compounds containing >C = O groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
- C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
- C07C45/67—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
- C07C45/68—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms
- C07C45/72—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction of compounds containing >C = O groups with the same or other compounds containing >C = O groups
- C07C45/74—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction of compounds containing >C = O groups with the same or other compounds containing >C = O groups combined with dehydration
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
- C07C49/20—Unsaturated compounds containing keto groups bound to acyclic carbon atoms
- C07C49/203—Unsaturated compounds containing keto groups bound to acyclic carbon atoms with only carbon-to-carbon double bonds as unsaturation
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/0803—Compounds with Si-C or Si-Si linkages
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/0803—Compounds with Si-C or Si-Si linkages
- C07F7/081—Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te
- C07F7/0812—Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te comprising a heterocyclic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/14—The ring being saturated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/16—Systems containing only non-condensed rings with a six-membered ring the ring being unsaturated
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Neurosurgery (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB838329531A GB8329531D0 (en) | 1983-11-04 | 1983-11-04 | Pyrazolopyridine cycloalkanones |
Publications (1)
Publication Number | Publication Date |
---|---|
NO844376L true NO844376L (no) | 1985-05-06 |
Family
ID=10551272
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO844376A NO844376L (no) | 1983-11-04 | 1984-11-02 | Fremgangsmaate for fremstilling av terapeutisk aktive pyrazolopyridin-cykloalkanon-derivater |
Country Status (14)
Country | Link |
---|---|
US (1) | US4546104A (da) |
EP (1) | EP0141608A3 (da) |
JP (1) | JPS60115581A (da) |
AU (1) | AU3494984A (da) |
DK (1) | DK522984A (da) |
ES (1) | ES537338A0 (da) |
FI (1) | FI844296L (da) |
GB (1) | GB8329531D0 (da) |
GR (1) | GR80777B (da) |
HU (1) | HUT35679A (da) |
IL (1) | IL73374A0 (da) |
NO (1) | NO844376L (da) |
PT (1) | PT79448B (da) |
ZA (1) | ZA848352B (da) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8610981D0 (en) * | 1986-05-06 | 1986-06-11 | Ici America Inc | Quinoline amides |
GB8610980D0 (en) * | 1986-05-06 | 1986-06-11 | Ici America Inc | Heterocyclic fused tricyclic compounds |
US4753950A (en) * | 1986-11-24 | 1988-06-28 | Hoechst-Roussel Pharmaceuticals, Inc. | Fused heterocyclic tetrahydroaminoquinolinols and related compounds |
US20030220646A1 (en) * | 2002-05-23 | 2003-11-27 | Thelen Sarah L. | Method and apparatus for reducing femoral fractures |
US7037902B2 (en) * | 2002-07-03 | 2006-05-02 | Receptron, Inc. | Affinity small molecules for the EPO receptor |
US7465795B2 (en) * | 2005-12-20 | 2008-12-16 | Astrazeneca Ab | Compounds and uses thereof |
CA2634305A1 (en) * | 2005-12-20 | 2007-06-28 | Marc Chapdelaine | Substituted cinnoline derivatives as gabaa-receptor modulators and method for their synthesis |
BRPI0710732A2 (pt) | 2006-04-24 | 2011-11-08 | Allergan Inc | canabidióis anormais como agentes para redução da pressão intraocular |
AR067028A1 (es) * | 2007-06-19 | 2009-09-30 | Astrazeneca Ab | Compuestos y usos de los mismos 849 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE1445719A1 (de) * | 1961-03-21 | 1969-01-09 | Bayer Ag | Verfahren zur Herstellung von 4-Chlor- oder 4-Brom-pyrazolo[3,4-]chinolinen |
GB1355205A (en) * | 1971-08-17 | 1974-06-05 | Bristol Myers Co | Di-alkylaminoalkylamino-pyrazolo-3,4b-quinolines and a process for the preparation thereof |
US4018779A (en) * | 1976-03-25 | 1977-04-19 | E. R. Squibb & Sons, Inc. | Derivatives of 10,11-dihydrobenzo[4,5]cyclohepta[1,2-b]-pyrazolo[4,3-e]pyridine-5(1H)ones |
GB8310266D0 (en) * | 1982-05-12 | 1983-05-18 | Ici America Inc | Pyrazolopyridine compounds |
-
1983
- 1983-11-04 GB GB838329531A patent/GB8329531D0/en active Pending
-
1984
- 1984-10-11 US US06/659,615 patent/US4546104A/en not_active Expired - Fee Related
- 1984-10-23 EP EP84307272A patent/EP0141608A3/en not_active Withdrawn
- 1984-10-25 ZA ZA848352A patent/ZA848352B/xx unknown
- 1984-10-29 GR GR80777A patent/GR80777B/el unknown
- 1984-10-30 IL IL73374A patent/IL73374A0/xx unknown
- 1984-11-01 FI FI844296A patent/FI844296L/fi not_active Application Discontinuation
- 1984-11-02 DK DK522984A patent/DK522984A/da not_active Application Discontinuation
- 1984-11-02 HU HU844064A patent/HUT35679A/hu unknown
- 1984-11-02 PT PT79448A patent/PT79448B/pt unknown
- 1984-11-02 NO NO844376A patent/NO844376L/no unknown
- 1984-11-02 AU AU34949/84A patent/AU3494984A/en not_active Abandoned
- 1984-11-02 ES ES537338A patent/ES537338A0/es active Granted
- 1984-11-05 JP JP59231445A patent/JPS60115581A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
EP0141608A2 (en) | 1985-05-15 |
EP0141608A3 (en) | 1988-03-02 |
PT79448B (en) | 1986-11-13 |
DK522984D0 (da) | 1984-11-02 |
ES8603876A1 (es) | 1986-01-01 |
HUT35679A (en) | 1985-07-29 |
ES537338A0 (es) | 1986-01-01 |
GR80777B (en) | 1985-01-15 |
US4546104A (en) | 1985-10-08 |
DK522984A (da) | 1985-05-05 |
JPS60115581A (ja) | 1985-06-22 |
PT79448A (en) | 1984-12-01 |
AU3494984A (en) | 1985-05-09 |
IL73374A0 (en) | 1985-01-31 |
ZA848352B (en) | 1985-06-26 |
GB8329531D0 (en) | 1983-12-07 |
FI844296L (fi) | 1985-05-05 |
FI844296A0 (fi) | 1984-11-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US9447100B2 (en) | Substituted pyrazolo[1,5-A] pyrimidines as calcium receptor modulating agents | |
US4563525A (en) | Process for preparing pyrazolopyridine compounds | |
KR100548853B1 (ko) | 아졸로 트리아진 및 피리미딘 | |
AU724076B2 (en) | Substituted triazolo pyridazine derivatives as inverse agonists of the GABAAalpha5 receptor subtype | |
JP2690282B2 (ja) | イミダゾジアゼピン | |
MXPA06011423A (es) | Inhibidores de proteina cinasa heterobiciclica sustituida en el anillo 6,6-biciclico. | |
WO1996028429A1 (en) | 6-SUBSTITUTED PYRAZOLO [3,4-d] PYRIMIDIN-4-ONES AND COMPOSITIONS AND METHODS OF USE THEREOF | |
NO326701B1 (no) | Nye pyrrolderivater, deres anvendelse for fremstilling aav et medikament, samt farmasøytiske formuleringer som omfatter slike derivater | |
JPH047746B2 (da) | ||
AU2004290643A1 (en) | 5,7-diaminopyrazolo [4,3-d] pyrimidines with PDE-5 inhibiting activity | |
SU1577698A3 (ru) | Способ получени конденсированных производных пиррола | |
JP2004526768A (ja) | 子宮収縮抑制オキシトシン受容体拮抗薬としての三環系ジアゼピン | |
US20030004180A1 (en) | Pyrazolo-pyridine derivatives as ligands for gaba receptors | |
NO844376L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive pyrazolopyridin-cykloalkanon-derivater | |
JP2004527537A (ja) | 子宮収縮抑制オキシトシン受容体拮抗薬としての新規三環系ヒドロキシカルボキシアミド及びその誘導体 | |
NO840068L (no) | Heterocyklisk paakondenserte pyrazolo(3,4-d)pyridin-3-ioner | |
HU196403B (en) | Process for production of condensated tricyclic and heterocyclic compositions and medical preparatives containing them as active substance | |
EP0094175B1 (en) | Pyrazolopyridine compounds | |
US4705793A (en) | Pyrazolo[3,4-b]pyrrolo[3,4-e]pyridine-5(1H)-one and 1-H-pyrazolo[3,4-b][1,6]naphthyridine-5(6H)-one derivations, useful as anti-anxiety agents | |
HUT54162A (en) | Process for producing new substituted thienopyran derivatives and pharmaceutical compositions comprising such compounds | |
MXPA06005482A (es) | Procesos para la preparacion de pirazolo [1,5-a]-1,3,5-triazinas e intermediarios de los mismos. | |
AU641504B2 (en) | Tetrahydrobenzothienopyridines, processes for their preparation and their use as pharmaceuticals | |
NZ223736A (en) | Imidazodiazepine derivatives and pharmaceutical compositions | |
EP1430055B1 (en) | 7-tert-butyl-3-(2-fluorophenyl)-6-(2h-¬1,2,4|triazol-3-ylmethoxy)-¬1,2,4|triazolo¬4,3-b|pyridazine for the treatment of anxiety and convulsions | |
CA1256865A (en) | Oxadiazolylimidazobenzodiazepine, compositions, and method iii |